News
As of 2025, 23andMe — the once-prominent personal genomics and biotechnology company — is undergoing bankruptcy proceedings following a series of data breaches and financial troubles. This development ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback